Frequently asked questions

Data protection notice for legal entity and bank account validation regarding payments

European platform for regulatory science research meeting: June 2026 , Online, from 16 June 2026, 14:00 (CEST) to 16 June 2026, 18:00 (CEST)

Meeting summaries of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB)

Herbal medicinal product: Lecithinum ex soya, Glycine max (L.) Merr., P: Draft published

Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Zepzelca, lurbinectedin, Date of authorisation: 29/05/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 24, Status: Authorised